CINC inventory tumbles as blood strain candidate fails in mid-stage research (NASDAQ:CINC)
mphillips007 Cardio-renal drug developer CinCor Pharma (NASDAQ:CINC) misplaced ~27% pre-market Monday after asserting that its Part ...
Read more
mphillips007 Cardio-renal drug developer CinCor Pharma (NASDAQ:CINC) misplaced ~27% pre-market Monday after asserting that its Part ...
Read more